470 related articles for article (PubMed ID: 29780361)
1. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
Rossitto M; Fiscarelli EV; Rosati P
Front Microbiol; 2018; 9():775. PubMed ID: 29780361
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by
Fiscarelli EV; Rossitto M; Rosati P; Essa N; Crocetta V; Di Giulio A; Lupetti V; Di Bonaventura G; Pompilio A
Microorganisms; 2021 Feb; 9(3):. PubMed ID: 33668889
[TBL] [Abstract][Full Text] [Related]
3. Current knowledge in the use of bacteriophages to combat infections caused by Pseudomonas aeruginosa in cystic fibrosis.
Martínez-Gallardo MJ; Villicaña C; Yocupicio-Monroy M; Alcaraz-Estrada SL; León-Félix J
Folia Microbiol (Praha); 2023 Feb; 68(1):1-16. PubMed ID: 35931928
[TBL] [Abstract][Full Text] [Related]
4. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.
Olszak T; Zarnowiec P; Kaca W; Danis-Wlodarczyk K; Augustyniak D; Drevinek P; de Soyza A; McClean S; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2015 Jul; 99(14):6021-33. PubMed ID: 25758956
[TBL] [Abstract][Full Text] [Related]
6. Activity of Bacteriophages in Removing Biofilms of
Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
[No Abstract] [Full Text] [Related]
7. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
8. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.
Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L
Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933
[TBL] [Abstract][Full Text] [Related]
9. Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of
Martin I; Morales S; Alton EWFW; Davies JC
Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978460
[TBL] [Abstract][Full Text] [Related]
10. Novel Lytic Phages Protect Cells and Mice against
Chen F; Cheng X; Li J; Yuan X; Huang X; Lian M; Li W; Huang T; Xie Y; Liu J; Gao P; Wei X; Wang Z; Wu M
J Virol; 2021 Mar; 95(8):. PubMed ID: 33472935
[TBL] [Abstract][Full Text] [Related]
11. Phage therapy in lung infections caused by multidrug-resistant Pseudomonas aeruginosa - A literature review.
Eiselt VA; Bereswill S; Heimesaat MM
Eur J Microbiol Immunol (Bp); 2024 Feb; 14(1):1-12. PubMed ID: 38261031
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant
Camens S; Liu S; Hon K; Bouras GS; Psaltis AJ; Wormald PJ; Vreugde S
Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576896
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa.
Ong SP; Azam AH; Sasahara T; Miyanaga K; Tanji Y
J Biosci Bioeng; 2020 Jun; 129(6):693-699. PubMed ID: 32107153
[TBL] [Abstract][Full Text] [Related]
14. Phage-antibiotic combinations against multidrug-resistant
Holger DJ; El Ghali A; Bhutani N; Lev KL; Stamper K; Kebriaei R; Kunz Coyne AJ; Morrisette T; Shah R; Alexander J; Lehman SM; Rojas LJ; Marshall SH; Bonomo RA; Rybak MJ
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0057823. PubMed ID: 37855639
[TBL] [Abstract][Full Text] [Related]
15.
Vaitekenas A; Tai AS; Ramsay JP; Stick SM; Kicic A
Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33540528
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of effectiveness for phage cocktail development against multiple Salmonella serovars and its biofilm control activity.
Ribeiro JM; Pereira GN; Durli Junior I; Teixeira GM; Bertozzi MM; Verri WA; Kobayashi RKT; Nakazato G
Sci Rep; 2023 Aug; 13(1):13054. PubMed ID: 37567926
[TBL] [Abstract][Full Text] [Related]
17. Development and Evaluation of Bacteriophage Cocktail to Eradicate Biofilms Formed by an Extensively Drug-Resistant (XDR)
Vashisth M; Jaglan AB; Yashveer S; Sharma P; Bardajatya P; Virmani N; Bera BC; Vaid RK; Anand T
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851640
[TBL] [Abstract][Full Text] [Related]
18. The use of phages for the removal of infectious biofilms.
Azeredo J; Sutherland IW
Curr Pharm Biotechnol; 2008 Aug; 9(4):261-6. PubMed ID: 18691087
[TBL] [Abstract][Full Text] [Related]
19. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
